Document is current
Any future updates will be listed below
-
Authors
Jia, Wen-Hui
Huang, Chang-Ling
Zhang, Wen-Li
He, Yong-Qiao
Xue, Wen-Qiong
Liao, Ying
Zhao, Zhi-Yang
Yang, Meng-Xuan
Pei, Lu
Jia, Wei-Hua
Wang, Tong-Min
-
Funding
Funding for this research was provided by:
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China
National Natural Science Foundation of China (82473703, 82404339, 82273705, 82373656)
Science and Technology Planning Project of Guangzhou, China (2024A04J00693, 2024A04J4560)
Fundamental Research Funds for the Central Universities, Sun Yat-sen University (24qnpy292, 24ykgb002)
Young Talents Program of Sun Yat-sen University Cancer Center (YTP-SYSUCC-0081, YTP-SYSUCC-0076)
Young Science and Technology Talent Support Program of Guangdong Precision Medicine Application Association (YSTTGDPMAA202502)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0501000)
Cancer Innovative Research Program of Sun Yat-sen University Cancer Center (CIRP-SYSUCC-0017)
Young Talent Support Project of Guangzhou Association for Science and Technology (QT2024-030)
- License Information
-
More Information
Article History
Received: 28 January 2025
Accepted: 4 May 2025
First Online: 20 May 2025
Declarations
:
: The North West Multi-Centre Research Ethics Committee (MREC) has approved UK Biobank as a Research Tissue Bank (RTB) (21/NW/0157), allowing researchers to proceed without additional ethical approval. The FinnGen data used in this study were obtained from publicly available GWAS summary datasets, approved by the relevant ethics committees.
: All the participants involved in this study have provided written informed permission.
: The authors declare no competing interests.
